Synthorx competitorsClear all
Synthorx's top competitors include Cellestia Biotech, Deciphera Pharmaceuticals, UNITY Biotechnology and Heron Therapeutics.
| Save Comparison |  Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. |  Cellestia Biotech Cellestia Biotech is a biopharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway. |  Heron Therapeutics Heron Therapeutics is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform. | ||
Founding Date | Founding Date 2014 | Founding Date 2014 | Founding Date 2003 | Founding Date 2009 | Founding Date 1983 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Basel, CH HQ Epalinges, CH | Locations Waltham, US HQ Lawrence, US Waltham, US | Locations South San Francisco, US HQ | Locations San Diego, US HQ Jersey City, US |
Employees | Employees 3939% increase | Employees 6 | Employees 438% increase | Employees 98 | Employees 23117% increase |
Valuation ($) | Valuation ($) 2.2 b | Valuation ($) N/A | Valuation ($) 2.5 b | Valuation ($) 381 m | Valuation ($) 1.6 b |
Twitter followers | Twitter followers 838 | Twitter followers 147 | Twitter followers N/A | Twitter followers 3.6 k | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 1 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 6 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 2 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 11 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 443374 | Alexa Website Rank 383510 | Alexa Website Rank 296303 | Alexa Website Rank 334828 | Alexa Website Rank 354402 |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating 3.6 | Employee Rating 3.4 | Employee Rating N/A |
Financial | |||||
Net income | Net income ($5.9m) (FY, 2017) | Net income N/A | Net income ($25.9m) (FY, 2016) | Net income ($82.2m) (FY, 2019) | Net income ($227.3m) (FY, 2020) |
Funding | |||||
Total funding raised | Total funding raised $ 79m | Total funding raised $ 48.6m | Total funding raised $ 142m | Total funding raised $ 210.6m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Cellestia Biotech
HQ
Basel, CH
Employees
6
Cellestia Biotech is a biopharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway.
View company
Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
43↑ 8% increase
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company.
View company
UNITY Biotechnology
HQ
South San Francisco, US
Employees
98
Unity Biotechnology designs therapeutics that prevent various diseases of aging.
View companyHeron Therapeutics
HQ
San Diego, US
Employees
231↑ 17% increase
Heron Therapeutics is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform.
View company